Delivery Order SPE2DB24D8002-SPE2DB24FJMZW
Award Date
9/23/24
Potential Completion Date
9/24/24
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,623.79, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR, a pharmaceutical product, with a period of performance extending through July 23, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medication to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract has a firm fixed price of $10,101.69 and a completion date of June 16, 2025. Dakota Drug, Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR, a pharmaceutical product, with a ceiling value of $10,536.26 and a performance period ending on March 19, 2025. The contract is not set aside for any specific business type. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and...
Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, has been awarded a firm fixed price delivery order valued at $4,599.41 by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). Issued against an existing blanket purchase agreement with no set-aside designation, this delivery order provides BENLYSTA 200 MG/ML autoinjectors to support DLA Troop Support Medical supply chain operations and maintain stock...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The award, valued at $3,457.84, is a delivery order under the company's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop Support Medical's ECAT Generation V Program. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, identified as SPE2DB24D8001, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZDT, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,528.94 and is a Firm Fixed Price Delivery Order. It is not associated with a set-aside program. Dakota...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a firm fixed price of $1,928.41 and a completion date of June 25, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,194.99, is a firm fixed-price delivery order for the pharmaceutical product ZEPBOUND 15 MG/0.5 ML PEN 0.5ML. Dakota Drug, Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical division, awarded a Firm Fixed Price delivery order contract valued at $4,787.60 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of SKYLA 13.5 MG SYSTEMS medical supplies, with a performance period extending through April 25, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified...